Eyenovia
Eyenovia, Inc.
295 Madison Avenue, Suite 2400New York, NY 10017
Phone: (917) 289-1117Website: https://eyenovia.com/
Latest news
- FDA Approves Mydcombi (tropicamide and phenylephrine hydrochloride) Ophthalmic Spray for Inducing Mydriasis
8 May 2023 - Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi™ for In-Office Pupil Dilation
13 December 2022 - Eyenovia Announces FDA Acceptance of the MydCombi NDA
2 March 2021 - Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi
29 December 2020
Drugs Associated with Eyenovia, Inc.
Eyenovia, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Mydcombi
Generic name: phenylephrine/tropicamide Drug class: mydriatics |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
